Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.39 - $3.5 $123,328 - $180,607
-51,602 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.93 - $4.3 $42,701 - $62,668
14,574 Added 39.36%
51,602 $179,000
Q2 2020

Aug 17, 2020

BUY
$1.99 - $4.4 $73,685 - $162,923
37,028 New
37,028 $154,000
Q2 2019

Aug 14, 2019

SELL
$2.95 - $4.38 $61,301 - $91,016
-20,780 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$16.15 - $28.93 $8,478 - $15,188
525 Added 2.59%
20,780 $344,000
Q3 2018

Nov 14, 2018

BUY
$20.21 - $31.85 $409,353 - $645,121
20,255 New
20,255 $587,000

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.